Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study
- PMID: 11347286
Use of Iscador, an extract of European mistletoe (Viscum album), in cancer treatment: prospective nonrandomized and randomized matched-pair studies nested within a cohort study
Abstract
Context: In anthroposophical medicine, total extracts of Viscum album (mistletoe) have been developed to treat cancer patients. The oldest such product is Iscador. Although Iscador is regarded as a complementary cancer therapy, it is the most commonly used oncological drug in Germany.
Objective: To determine whether Iscador treatment prolongs survival time of patients with carcinoma of the colon, rectum, or stomach; breast carcinoma with or without axillary or remote metastases; or small cell or non-small-cell bronchogenic carcinoma; and to explore synergies between Iscador treatment and psychosomatic self-regulation.
Design: Prospective nonrandomized and randomized matched-pair studies nested within a cohort study.
Setting: General community in Germany.
Participants: 10,226 cancer patients involved in a prospective long-term epidemiological cohort study, including 1668 patients treated with Iscador and 8475 who had taken neither Iscador nor any other mistletoe product (control patients).
Intervention: Iscador.
Main outcome measure: Survival time.
Results: In the nonrandomized matched-pair study, survival time of patients treated with Iscador was longer for all types of cancer studied. In the pool of 396 matched pairs, mean survival time in the Iscador groups (4.23 years) was roughly 40% longer than in the control groups (3.05 years; P < .001). Synergies between Iscador treatment and self-regulation manifested in a longer survival advantage for Iscador patients with good self-regulation (56% relative to control group; P = .03) than for patients with poor self-regulation. Results of the 2 randomized matched-pair studies largely confirmed the results of the non-randomized studies.
Conclusion: Iscador treatment can achieve a clinically relevant prolongation of survival time of cancer patients and appears to stimulate self-regulation.
Similar articles
-
Prospective controlled cohort studies on long-term therapy of breast cancer patients with a mistletoe preparation (Iscador).Forsch Komplementmed. 2006 Oct;13(5):285-92. doi: 10.1159/000095378. Epub 2006 Oct 20. Forsch Komplementmed. 2006. PMID: 17057389 Clinical Trial.
-
Prospective controlled cohort studies on long-term therapy of ovairian cancer patients with mistletoe (Viscum album L.) extracts iscador.Arzneimittelforschung. 2007;57(10):665-78. doi: 10.1055/s-0031-1296666. Arzneimittelforschung. 2007. PMID: 18074761 Clinical Trial.
-
Randomised and non-randomised prospective controlled cohort studies in matched-pair design for the long-term therapy of breast cancer patients with a mistletoe preparation (Iscador): a re-analysis.Eur J Med Res. 2006 Nov 30;11(11):485-95. Eur J Med Res. 2006. PMID: 17182361 Clinical Trial.
-
Unconventional therapies for cancer: 3. Iscador. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.CMAJ. 1998 May 5;158(9):1157-9. CMAJ. 1998. PMID: 9597967 Free PMC article. Review. No abstract available.
-
Immune modulation using mistletoe (Viscum album L.) extracts Iscador.Arzneimittelforschung. 2006 Jun;56(6A):508-15. doi: 10.1055/s-0031-1296818. Arzneimittelforschung. 2006. PMID: 16927532 Review.
Cited by
-
Systematic assessment of the influence of quality of studies on mistletoe in cancer care on the results of a meta-analysis on overall survival.J Cancer Res Clin Oncol. 2024 Apr 29;150(4):219. doi: 10.1007/s00432-024-05742-1. J Cancer Res Clin Oncol. 2024. PMID: 38679615 Free PMC article.
-
Viscum album, as alternative and bridge to palliative chemotherapy in recurrent gallbladder cancer following laparoscopic radical cholecystectomy: a case report.Korean J Clin Oncol. 2023 Dec;19(2):88-92. doi: 10.14216/kjco.23016. Epub 2024 Dec 31. Korean J Clin Oncol. 2023. PMID: 38229495 Free PMC article.
-
Clinical characteristics and therapeutic behavior of breast cancer patients using mistletoe therapy consulting a clinic offering integrative oncology: a registry data analysis.BMC Complement Med Ther. 2023 Nov 3;23(1):395. doi: 10.1186/s12906-023-04219-x. BMC Complement Med Ther. 2023. PMID: 37924102 Free PMC article.
-
The Introspective Patient Experience of Mistletoe Therapy in Cancer: A Qualitative Study.Integr Cancer Ther. 2023 Jan-Dec;22:15347354231198474. doi: 10.1177/15347354231198474. Integr Cancer Ther. 2023. PMID: 37731253 Free PMC article.
-
The Anti-Inflammatory Activity of Viscum album.Plants (Basel). 2023 Mar 27;12(7):1460. doi: 10.3390/plants12071460. Plants (Basel). 2023. PMID: 37050086 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical